Lysoclear

About:

Lysoclear is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease.

Top Investors: KIZOO Technology Capital, Grapeseed.Bio

Description:

Lysoclear, Inc. is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease. The company is currently developing leads to treat atrophic “dry” age-related macular degeneration and Stargardt’s macular degeneration.

Total Funding Amount:

$3M

Headquarters Location:

Lafayette, Louisiana, United States

Founded Date:

2016-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2018-12-19

IPO Status:

Private

Industries: